Align Technology, Inc.

ALGN · NasdaqGS · Stock · Healthcare
$144.44
+0.63% today
Delayed price,

What Align Technology does

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$10.26B
P/E (ttm)
24.9
Forward P/E
11.6
Dividend yield
0.00%
Beta
1.67
Profit margin
10.0%
Employees
20,435
Headquarters
Tempe, AZ, United States
Exchange
NasdaqGS

Performance

1 Month
-2.1%
3 Months
-18.3%
6 Months
-24.0%
1 Year
+10.7%
5 Years
-76.4%
$128.6552-week range$200.44
Biggest setback — last 12 months
-24.9%
23 Feb 2026 → 5 Oct 2026
Fell from $190.10 to $142.71 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+45.7%
13 Oct 2025 → 23 Feb 2026
Ran from $130.45 to $190.10 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▼ Trend: Downtrend
Price is below its 20-, 50- and 200-day averages, each stacked below the next — a classic technical downtrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$129.95 (-10.0%)$144.44$160.54 (+11.1%)
3 Months$120.28 (-16.7%)$144.44$173.46 (+20.1%)
6 Months$111.49 (-22.8%)$144.44$187.13 (+29.6%)
12 Months$100.15 (-30.7%)$144.44$208.31 (+44.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 36.6%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 1,376 shares — Blackford Quentin S., Director · 2026-08-31
Acquired 1,443 shares — Vitalone Britt J., Director · 2026-05-22
Acquired 1,745 shares — SIEGEL SUSAN E, Director · 2026-05-22
Acquired 1,745 shares — Saia Andrea Lynn, Director · 2026-05-22
Acquired 1,745 shares — Poul Mojdeh, Director · 2026-05-22
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.